Induction Chemotherapy Plus Concurrent Chemoradiation Therapy (ICCRT) Versus Concurrent Chemoradiation Therapy (CRT) in the Treatment of Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Chang, J. [1 ]
Moon, S. [2 ]
Cho, K. [2 ]
Kim, T. [2 ]
Kim, H. [1 ]
Wu, H. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Res Inst & Hosp, Natl Canc Ctr, Proton Therapy Ctr, Gyeonggi Do, South Korea
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.1472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S552 / S552
页数：1
相关论文
共 50 条
  • [1] Outcome of Concurrent Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer
    Liu, L.
    Ji, Z.
    Cao, J.
    Wang, J.
    Hui, Z.
    Liang, J.
    Wang, X.
    Lv, J.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S648 - S648
  • [2] Induction Concurrent Chemoradiation Therapy for Invading Apical Non-Small Cell Lung Cancer
    Miyoshi S.
    Iuchi K.
    Nakamura K.
    Nakagawa K.
    Maeda H.
    Ohno K.
    Nakahara K.
    Nakano N.
    Okumura M.
    Ohta M.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 2004, 52 (3) : 120 - 126
  • [3] Concurrent durvalumab plus chemoradiation therapy followed by durvalumab in Chinese patients with unresectable stage III non-small cell lung cancer: CRUISER study
    Teng, Feifei
    Ge, Hong
    Wang, Buhai
    Xu, Yaping
    Meng, Xue
    Wang, Suzhen
    Xing, Ligang
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Treatment outcome and safety of concurrent chemoradiation in elderly patients with unresectable Stage III non-small cell lung cancer
    Kim, So Jeong
    Kim, Na Young
    Chung, Soojie
    Choi, Jeong-Hee
    Hyun, In Gyu
    Kim, Junghyun
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [5] Optimizing chemoradiation therapy approaches to unresectable stage III non-small cell lung cancer
    Gaspar, LE
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (02) : 110 - 115
  • [6] Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
    Price, Katharine A. R.
    Azzoli, Christopher G.
    Gaspar, Laurie E.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2008, 20 (03) : 204 - 209
  • [7] Outcomes for Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Treated With Concurrent Chemotherapy and Radiation Therapy to 70 Gy
    Freilich, J.
    Baker, R.
    Stevens, C. W.
    Fulp, W. J.
    DeMarco, M.
    Turke, C.
    Dilling, T. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S572 - S572
  • [8] Outcomes For Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) Treated With Concurrent Chemotherapy And Radiation Therapy To 70 Gy
    Freilich, J.
    Baker, R.
    Stevens, C. W.
    Fulp, W. J.
    DeMarco, M.
    Turke, C.
    Dilling, T. J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S270 - S270
  • [9] A Comparison of Trimodality Therapy Versus Definitive Concurrent Chemoradiation in Patients With Stage IIIA Non-small Cell Lung Cancer
    Shepherd, A. F.
    Leeman, J. E.
    Wild, A.
    Imber, B. S.
    Pei, X.
    Gelb, E.
    Yorke, E. D.
    Isbell, J.
    Chaft, J.
    Gelblum, D.
    Wu, A. J.
    Rimner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E495 - E496
  • [10] Phase 3 study of pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with or without olaparib versus concurrent chemoradiation therapy followed by durvalumab in unresectable, locally advanced, stage III non-small cell lung cancer: KEYLYNK-012.
    Jabbour, Salma K.
    Cho, Byoung Chul
    Bria, Emilio
    Kato, Terufumi
    Bhosle, Jaishree
    Gainor, Justin F.
    Reguart, Noemi
    Wang, Luhua
    Morgensztern, Daniel
    Gurary, Ellen
    Ashraf, Tanya B.
    Lara-Guerra, Humberto
    Reck, Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345